No Picture
News

VBI Vaccines Reports Full Year 2023 Financial Results

CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the year ended December 31, 2023. “Over the last 12 months, we’ve seen continued progress across… … […]

No Picture
News

Vizgen Issued a New US Patent for Its MERFISH Technology

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announced today the issuance by the US Patent Office of a patent that covers the in situ imaging of the spatial transcriptome. U.S. Patent No. 11,959,075 is for robust multiplex imaging… … […]

No Picture
News

Neumora’s schizophrenia drug hit with clinical hold

Shares of Neumora Therapeutics fell Monday after the company disclosed a small clinical trial testing one of its experimental medicines for schizophrenia has been halted by the Food and Drug Administration. According to Neumora, the hold comes on the heels of new data from animal testing that found… … […]

No Picture
News

BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, and Saga University located in Saga, Japan and known for its commitment to educating and training researchers and professionals in the medical and healthcare fields, announced today the launch of a collaboration aimed at discovering biomarkers for… … […]

No Picture
News

GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 15, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the April 15, 2024 French legal announcements bulletin n°46… … […]

News

Federal judge pauses Covid-19 patent lawsuit trial against Pfizer, BioNTech

A federal judge has ruled that Moderna’s lawsuit against Pfizer and BioNTech will be put on hold, while the US Patent and Trademark Office reviews petitions brought against two of the three Covid-19 vaccine-related patents that Moderna feels have been infringed. In a ruling published Friday, a Massachusetts federal judge… … […]